Oncolytics Biotech Inc. Files July 2024 6-K Report
Ticker: ONCY · Form: 6-K · Filed: Jul 24, 2024 · CIK: 1129928
| Field | Detail |
|---|---|
| Company | Oncolytics Biotech INC (ONCY) |
| Form Type | 6-K |
| Filed Date | Jul 24, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, sec-report
TL;DR
ONCOLYTICS BIOTECH INC. filed their July 6-K, confirming foreign private issuer status and 20-F annual report filings.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on July 24, 2024, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is involved in the pharmaceutical preparations industry. This filing is for the month of July 2024 and indicates they file annual reports under Form 20-F.
Why It Matters
This filing provides an update on Oncolytics Biotech Inc.'s regulatory reporting status as a foreign private issuer, which is important for investors tracking their compliance and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine regulatory report and does not contain new financial or operational information that would typically increase risk.
Key Numbers
- 001-38512 — SEC File Number (Identifies the company's registration with the SEC.)
Key Players & Entities
- ONCOLYTICS BIOTECH INC (company) — Filer
- 20240724 (date) — Filing Date
- July 2024 (date) — Reporting Period
- Calgary, Alberta, Canada (location) — Company Headquarters
- 2834 (industry_code) — Standard Industrial Classification
- 001-38512 (sec_file_number) — SEC File Number
FAQ
What is the primary purpose of this Form 6-K filing?
This Form 6-K filing serves as a report of a foreign private issuer for the month of July 2024, providing updates as required by the SEC.
What is Oncolytics Biotech Inc.'s Standard Industrial Classification (SIC) code?
Oncolytics Biotech Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Does Oncolytics Biotech Inc. file annual reports under Form 20-F or 40-F?
The filing indicates that Oncolytics Biotech Inc. files annual reports under cover of Form 20-F.
Where is Oncolytics Biotech Inc. headquartered?
Oncolytics Biotech Inc. is headquartered in Calgary, Alberta, Canada.
What is the SEC file number for Oncolytics Biotech Inc.?
The SEC file number for Oncolytics Biotech Inc. is 001-38512.
Filing Stats: 334 words · 1 min read · ~1 pages · Grade level 17.1 · Accepted 2024-07-24 13:34:55
Filing Documents
- form6kq22024date.htm (6-K) — 18KB
- oncyq22024callpr.htm (EX-99.1) — 11KB
- 0001129928-24-000052.txt ( ) — 29KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Oncolytics Biotech Inc. (Registrant) By s Kirk Look Date July 24, 2024 Kirk Look Chief Financial Officer